Postgraduate research opportunities Chance & Necessity: navigating the strain improvement fitness landscape

Apply

Key facts

  • Opens: Monday 4 July 2022
  • Number of places: 1
  • Duration: 3 years

Overview

The project will study the evolution and adaptation of Streptomyces bacteria as a means to understanding how antibiotic production evolves and the epistatic interactions that govern production.
Back to opportunity

Eligibility

First class or 2.1 Degree (or equivalent) in Microbiology, Biochemistry, Molecular biology, or Evolutionary Biology.

THE Awards 2019: UK University of the Year Winner
Back to opportunity

Project Details

Antimicrobial resistance (AMR) is one of the greatest threats to global human health and we need to develop novel approaches to discover new molecules and enhance production of existing molecules. Currently two-thirds of our clinically used antimicrobial drugs are specialised (secondary) metabolites produced by the genus Streptomyces. The traditional process for the development of Streptomyces strains for industrial antibiotic production has been through iterative random mutagenesis followed by the selection of strains with improved production characteristics – this process is undirected and time consuming. The key mutations within these strains, that drive increased industrial performance are often poorly understood and are likely to be the result of cumulative negative effects during multiple rounds of mutation and selection. To address this, we have been using a dual approach to understand evolution of antibiotic production in Streptomyces – a long term evolution experiments of adaptation in Streptomyces and a study of an authentic, industrially improved lineage (forced evolution; FE) of Streptomyces. These studies have shown how adaptation in the LTEE and in the FE results in streamlining of primary metabolism, loss of catabolic breadth and the degradation of competing specialised metabolic pathways. This loss of catabolic capability impacts on growth and yield of antibiotics. Reconditioning of strains with collaterally damaged primary metabolic pathways enabled increased antibiotic titres to be achieved in some industrial strains. Genomics and transcriptomics of evolved strains reveals extensive chromosomal plasticity and transcriptional re-wiring. This project will build on existing studies and attempt to understand the wider role of genetic interactions and how strains may have adapted in culture to enable the process of strain improvement to be accelerated in the future through informed strain engineering.

Back to opportunity

Funding details

This opportunity is unfunded.

Back to opportunity

Supervisors

Professor Hoskisson

Professor Paul Hoskisson

Strathclyde Institute of Pharmacy and Biomedical Sciences

View profile
Back to course

Apply

Please apply via the PhD Pharmacy & Biomedical Sciences course page.

Number of places: 1

To read how we process personal data, applicants can review our 'Privacy Notice for Student Applicants and Potential Applicants' on our Privacy notices' web page.

Back to course

Contact us

Professor Paul A Hoskisson, paul.hoskisson@strath.ac.uk